To the users of the by vnc74534

VIEWS: 26 PAGES: 7

									ALTERATIONS IN ATC CLASSIFICATION
valid from January 2006


sorted according to previous ATC code

Previous               ATC level name                          New ATC code
ATC code

B01AC14                Anagrelide                              L01XX35


C04AX13                Piribedil                               N04BC08


C10AA51                Simvastatin, combinations               C10BX01*


C10AA52                Lovastatin, combinations                C10BA01*


C10AA53                Pravastatin, combinations               C10BX02*


C10AA55                Atorvastatin, combinations              C10BX03*



*     An alteration in the name of this ATC level has been performed. See separate list: Other
      alterations in ATC classification



WHO-Oslo, 23 November 2005
HSB/IL/CBL/tg




F.\\.....\\who\endring\endringer 2006\atcalt2006.doc
OTHER ALTERATIONS IN ATC CLASSIFICATION,
i.e. NEW LEVELS (this list includes only new levels assigned in connection with an
alteration), DELETED LEVELS AND ALTERED NAMES OF ATC LEVELS

valid from January 2006

sorted according to ATC code



ATC code                      Previous ATC level name                 New ATC level name or
                                                                      new ATC level

C10                           Serum lipid reducing agents             Lipid modifying agents

C10A                          Cholesterol and triglyceride reducers   Lipid modifying agents, plain

C10AX                         Other cholesterol and triglyceride      Other lipid modifying agents
                              reducers

C10BA01                       Lovastatin, combinations                Lovastatin and nicotinic acid
                              (previous ATC code: C10AA52)

C10BX01                       Simvastatin, combinations               Simvastatin and acetylsalicylic
                              (previous ATC code: C10AA51)            acid

C10BX02                       Pravastatin, combinations               Pravastatin and acetylsalicylic acid
                              (previous ATC code: C10AA53)
C10BX03                       Atorvastatin, combinations              Atorvastatin and amlodipine
                              (previous ATC code: C10AA55)
H05B                          Anti-parathyroid hormones               Anti-parathyroid agents

L01XD                         Agents used in photodynamic therapy     Sensitizers used in
                                                                      photodynamic/radiation therapy

V04CG03                       Histamine                               Histamine phosphate




WHO-Oslo, 23 November 2005
HSB/HS/CLB/tg




F.\\.....\\who\endring\endringer 2006\atcalt2006.doc
ALTERATIONS IN DDDs

valid from January 2006

ATC code          ATC level name                          Previous DDD   New DDD

J05AE05           Amprenavir                              2.4   g    O   1.2   g    O

L04AA10           Sirolimus                               6     mg   O   3     mg   O




   WHO-Oslo, 23 November 2005
   HSB/HS/CLB/tg




   F.\\.....\\who\endring\endringer 2006\atcalt2006.doc
NEW ATC CODES
valid from January 2006

ATC code ATC level name -English

A03AE03            Cilansetron
A11CC07            Paricalcitol
A11DA03            Benfotiamine
A16AB07            Alglucosidase alfa
A16AB08            Galsulfase
B01AC21            Treprostinil
B01AE06            Bivalirudin
C01EB17            Ivabradine
C01EB18            Ranolazine
C09BA15            Zofenopril and diuretics
C09BB02            Enalapril and calcium channel blockers
C10B               Lipid modifying agents, combinations
C10BA              HMG CoA reductase inhibitors in combination with other lipid modifying agents
C10BA02            Simvastatin and ezetimibe
C10BX              HMG CoA reductase inhibitors, other combinations
D06BA05            Sulfanilamide
D06BA06            Sulfamerazine
D09AA13            Iodoform
H05BX              Other anti-parathyroid agents
H05BX01            Cinacalcet
J01DC11            Ceforanide
J01DD16            Cefditoren
J01MA17            Prulifloxacin
J01RA04            Spiramycin, combinations with other antibacterials
J02AC04            Posaconazole
J02AX06            Anidulafungin
J05AB15            Brivudine
J05AE08            Atazanavir
J05AE09            Tipranavir
J05AF10            Entecavir
J07BD54            Measles, combinations with mumps, rubella and varicella, live attenuated
L01BB06            Clofarabine
L01XD06            Efaproxiral
L01XX34            Erlotinib

F.\\.....\\who\endring\endringer 2006\atcalt2006.doc
ATC code ATC level name -English

L03AX14            Histamine dihydrochloride
L04AA22            Abetimus
L04AA23            Natalizumab
M05BB02            Risedronic acid and calcium
N03AF03            Rufinamide
N03AX16            Pregabalin
N04BC09            Rotigotine
N05CM18            Dexmedetomidine
N06AX21            Duloxetine
N06AX22            Agomelatine
N06BA10            Fenetylline
P01AX10            Fumagillin
R01AC08            Olopatadine
R03DX07            Roflumilast
R05DA12            Acetyldihydrocodeine
R05DB28            Dimethoxanate
S01AX21            Gatifloxacin
S01BA14            Loteprednol
S01XA17            Pegaptanib
V03AF08            Palifermin
V08CA10            Gadoxetic acid
V10XX02            Ibritumomab tiuxetan [90Y]




WHO-Oslo, 23 November 2005
HSB/HS/CLB/tg




F.\\.....\\who\endring\endringer 2006\atcalt2006.doc
 NEW DDDs
 valid from January 2006


ATC code            ATC level name                      New DDD

A02BC05             Esomeprazole                          30 mg    P

B01AC11             Iloprost                             0.15 mg   inhal

B01AC21             Treprostinil                          4.3 mg   P

B01AE04             Melagatran                             6 mg    P

B01AE05             Ximelagatran                          48 mg    O

B01AE06             Bivalirudin                          0.25 g    P

C03DA04             Eplerenone                            50 mg    O

G04BD04             Oxybutynin                            3.9 mg   TD

G04BD09             Trospium                              40 mg    O

G04BD10             Darifenacin                           7.5 mg   O

J01DC11             Ceforanide                             4 g     P

J01FA10             Azithromycin                          0.5 g    P

J01MA14             Moxifloxacin                          0.4 g    P

J05AB15             Brivudine                           0.125 g    O

J05AE07             Fosamprenavir                         1.4 g    O

J05AE08             Atazanavir                            0.3 g    O

J05AF09             Emtricitabine                         0.2 g    O

L04AA21             Efalizumab                            10 mg    P

M01AB11             Acemetacin                           0.12 g    O


 F.\\.....\\who\endring\endringer 2006\atcalt2006.doc
ATC code            ATC level name                                New DDD

M01AE17             Dexketoprofen                                   75 mg    P

M05BX03             Strontium ranelate                               2 g     O


N02CC03             Zolmitriptan                                    2.5 mg   N

N03AX15             Zonisamide                                      0.2 g    O

N03AX16             Pregabalin                                      0.3 g    O

N04BA03             Levodopa, decarboxylase inhibitor and COMT-    0.45 g*   O
                    inhibitor
N06AB04             Citalopram                                      20 mg    P

N06AX21             Duloxetine                                      60 mg    O

N07BA01             Nicotine                                        30 mg    SL

P01BE02             Artemether                                     120 mg    P

R03BA08             Ciclesonide                                    0.16 mg   Inhal. aerosol

R03DX05             Omalizumab                                      16 mg    P

R05CB06             Ambroxol                                       0.12 g    O

R05DA12             Acetyldihydro-codeine                           30 mg    O

V03AE02             Sevelamer                                       6.4 g    O

V03AE03             Lanthanum carbonate                            2.25 g#   O



 * expressed as levodopa
 # expressed as lanthanum

 WHO-Oslo, 23 November 2005
 HSB/HS/CLB/tg




 F.\\.....\\who\endring\endringer 2006\atcalt2006.doc

								
To top